This post is from a suggested group
UK Clinical Trials
The United Kingdom has long been recognized as a global powerhouse for clinical trials, supported by the integrated nature of the National Health Service (NHS) and a robust regulatory environment provided by the MHRA.
The ability to access a diverse and large-scale patient pool through a single centralized system allows for efficient recruitment and longitudinal data collection. Following recent global health events, the UK has pioneered decentralized trial models, utilizing digital health tools and remote monitoring to bring the trial to the patient’s home, thereby increasing retention and diversity in participation.
The focus of UK trials is increasingly leaning toward "platform trials" and "adaptive designs." Unlike traditional trials that test one drug against one placebo, platform trials like RECOVERY or STAMPEDE allow multiple treatments to be tested simultaneously against a common control group. This approach is significantly more efficient, as it allows for the rapid addition or removal of treatment…